MethylphenidateAmphetamineCentral Nervous System StimulantsAmphetaminesAttention Deficit Disorder with HyperactivityDextroamphetamineDopamine Uptake InhibitorsPropylaminesMethamphetamineAmphetamine-Related DisordersDopamine Plasma Membrane Transport ProteinsAdrenergic Uptake InhibitorsDopamineMotor ActivityBehavior, AnimalStereotyped BehaviorDopamine AgentsDose-Response Relationship, DrugCocaineSubstance Abuse DetectionHyperkinesisRats, Sprague-DawleyN-Methyl-3,4-methylenedioxyamphetamineDelayed-Action PreparationsRacloprideCorpus StriatumNucleus AccumbensNomifensineConditioning, OperantSelf AdministrationDouble-Blind Method3,4-MethylenedioxyamphetamineGas Chromatography-Mass SpectrometryNorepinephrine Plasma Membrane Transport ProteinsCross-Over StudiesDopamine AntagonistsBiogenic MonoaminesExploratory BehaviorPlacebosPemolineReceptors, Dopamine D2MethyltyrosinesRewardStreet DrugsVesicular Monoamine Transport ProteinsApathyDesigner DrugsBrainSubstance-Related DisordersReinforcement ScheduleAppetite DepressantsConditioning (Psychology)Dopamine AgonistsNeostriatumCocaine-Related DisordersImpulsive BehaviorReinforcement (Psychology)Alkalosis, RespiratoryChoice BehaviorSorboseMicrodialysisDrug and Narcotic ControlAnorexiaDrug InteractionsPrefrontal CortexAdministration, OralBiogenic AminesReceptors, Dopamine D4Inhibition (Psychology)NeurofeedbackPsychopharmacologyReceptors, DopamineCaudate NucleusPrescription Drug MisuseDrug Administration Schedule